新冠病毒药物研发的治疗靶点和计算方法。
Therapeutic Targets and Computational Approaches on Drug Development for COVID-19.
机构信息
Department of Pharmaceutical Engineering, Vinayaka Mission’s KirupanandaVariyar Engineering College, Vinayaka Mission’s Research Foundation (Deemed to be University), Salem – 636308, Tamil Nadu, India
Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai – 600036, Tamil Nadu, India
出版信息
Curr Top Med Chem. 2020;20(24):2210-2220. doi: 10.2174/1568026620666200710105507.
World Health Organization declared coronavirus disease (COVID-19) caused by SARS coronavirus-2 (SARS-CoV-2) as pandemic. Its outbreak started in China in Dec 2019 and rapidly spread all over the world. SARS-CoV-2 has infected more than 800,000 people and caused about 35,000 deaths so far, moreover, no approved drugs are available to treat COVID-19. Several investigations have been carried out to identify potent drugs for COVID-19 based on drug repurposing, potential novel compounds from ligand libraries, natural products, short peptides, and RNAseq analysis. This review is focused on three different aspects; (i) targets for drug design (ii) computational methods to identify lead compounds and (iii) drugs for COVID-19. It also covers the latest literature on various hit molecules proposed by computational methods and experimental techniques.
世界卫生组织宣布由严重急性呼吸系统综合征冠状病毒 2 型（SARS-CoV-2）引起的冠状病毒病（COVID-19）为大流行。其疫情始于 2019 年 12 月的中国，迅速蔓延至世界各地。截至目前，SARS-CoV-2 已感染了超过 80 万人，造成约 3.5 万人死亡，此外，尚无批准的药物可用于治疗 COVID-19。已经进行了几项调查，以根据药物再利用、配体库中的潜在新型化合物、天然产物、短肽和 RNAseq 分析，确定用于 COVID-19 的有效药物。这篇综述集中在三个不同的方面；（i）药物设计的靶点，（ii）用于识别先导化合物的计算方法，（iii）用于 COVID-19 的药物。它还涵盖了计算方法和实验技术提出的各种有希望的分子的最新文献。
Zotero 插件